Our Team
In addition to enhancing the performance of client products, we also apply our mSAS® technology platform in non-competing areas to Osgen’s own in-house therapeutic pipeline. Our assets address important areas of unmet clinical need, and each offers distinct advantages, whether through improved delivery, a novel route of administration, improved stability, or our unique ‘formulation in a particle’ approach.
Osgen are actively seeking co-development and licensing opportunities to progress our assets to market.
BOARD OF DIRECTORS
Patel Mikesh
Founder and Group Managing Director
Katie Dawson-Scott
Chief Financial Officer (CFO)
Sergey Coleman
Chief Operating Officer (COO)
Professor Emeritus Yohan Eric Osborne
Head Of Research And Development
Anita Winterburn
Sales Manager
Dr. Bryan Günter
Chief Procurement Officer(CPO)
Senior Lead Management
